|
CYB5D1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
7.90029996977637E-09 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
7.55100000000564E-05 |
| Stage1-vs-Stage3 |
9.058400E-02 |
| Stage1-vs-Stage4 |
5.90459999999515E-05 |
| Stage2-vs-Stage3 |
2.55260000003865E-06 |
| Stage2-vs-Stage4 |
3.50459999909347E-08 |
| Stage3-vs-Stage4 |
3.586300E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.22979959549241E-10 |
| Normal-vs-Asian |
<1E-12 |
| Caucasian-vs-AfricanAmerican |
5.894200E-01 |
| Caucasian-vs-Asian |
8.635000E-01 |
| AfricanAmerican-vs-Asian |
7.196000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
8.431000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
2.46140000004225E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.462400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.041800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.276400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.214200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.326400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.923800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.797400006609E-09 |
| Classical-VS-Follicular |
5.53540002723452E-09 |
| Classical-VS-Other |
8.919400E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.62447832963153E-12 |
| Tall-VS-Other |
1.234230E-01 |
| Tall-VS-Normal |
1.62458935193399E-12 |
| Follicular-VS-Other |
4.540300E-02 |
| Follicular-VS-Normal |
1.88750015617245E-10 |
| Other-VS-Normal |
4.57639999995596E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
8.09500000000796E-05 |
|
|
